Baidu
map

京津冀皮肤科中西医融合发展联盟在京成立

2017-12-25 刘映 新华网

中医、西医各有所长,紧密配合,有助于优势互补。为推进京津冀协同发展战略,12月24日,“京津冀皮肤科中西医融合发展联盟”在北京宣布成立,并发布了人民卫生出版社出版的新书《精诚大医赵炳南》。据悉,联盟由首都医科大学附属北京中医医院主办,北京中医医院皮肤科承办,京津冀三地中西医结合学会协办。

中医、西医各有所长,紧密配合,有助于优势互补。为推进京津冀协同发展战略,12月24日,“京津冀皮肤科中西医融合发展联盟”在北京宣布成立,并发布了人民卫生出版社出版的新书《精诚大医赵炳南》。据悉,联盟由首都医科大学附属北京中医医院主办,北京中医医院皮肤科承办,京津冀三地中西医结合学会协办。

“传承大师是为了出大师。”北京市中医管理局局长屠志涛表示,要加强对名老中医的传承发展,尽快建立代表性传承人的标准,分出层级,尽快推动名家医术用于临床,并形成规范、品牌。此外,还要加强中西融合,关键是人的融合以及工作之间的磨合。



随着社会经济的发展、环境的变化以及生活方式的改变,皮肤病对生活质量的影响越来越受到人们的重视。很多皮肤病是慢性复发性疾病,皮肤损害暴露于外,影响外观,由于病因不清,缺乏特效治疗方法,一旦患病,对患者的身心造成巨大痛苦。

对于病因不清、影响因素众多、病情复杂的疾病,中医学具有一定的优势,通过整体调理,内外合治,可以取得较好的疗效。同时,对于需要长期治疗的疾病来说,中医药由于多采用天然药物治疗,副作用相对较小。北京中医医院院长刘清泉表示,我国的古代医籍记载了大量对皮肤病的认识及治疗方法,现代中医皮肤科学奠基人赵炳南教授更是集60余年的临床经验,形成了中医皮肤病学的理论体系及诊疗方法,这些方法在皮肤病的诊疗中发挥着重要作用。早在1949年前后,赵炳南就与西医医院的医生紧密合作,解决了众多疑难皮肤问题。时至今日,中西医皮肤科医师仍然互相协作,旨在更好地解决皮肤问题。

联盟主席、北京中医医院皮肤科主任周冬梅表示,京津冀皮肤科中西医融合发展联盟为中西医皮肤科融合发展搭建了协作平台,联盟整合了京津冀地区中医、西医以及中西医结合皮肤科的优势资源,共有55家加盟单位,联盟将建立疑难病例会诊平台,在联盟内部建立疑难危重病人转诊绿色通道和慢性疾病患者就近诊疗推荐方案;举办各类学术交流活动,进行“中医学习西医”和“西医学习中医”的专题培训,并编制京津冀皮肤科中西医融合协编教材;整合联盟内优势资源,形成优势互补,制定及修订适合本区域的中西医融合皮肤科行业诊疗规范,积极推广联盟内部研究成果、特色疗法和优势诊疗方案;建设科研合作、人才培养开放协作平台,针对重点病种和临床难点进行联合攻关,组织申报各级别多中心课题。努力提升本地区皮肤科总体诊疗水平,联合攻关,形成地区优势,同时带动区域内基层医疗机构的皮肤科的中西医结合事业的全面发展,并为实现分级诊疗体系搭建框架体系。

当日还举行了中西医融合培训班,来自京津冀的众多中西医皮肤科知名专家进行了授课,如北京中医医院皮肤科王萍教授介绍了《红斑狼疮皮损辨析及治疗思路》,北京大学第一医院皮肤性病科副主任涂平教授介绍了《基于皮疹分析的临床诊断,提高皮肤科医生诊断水平的必由之路》,石家庄市中医院李领娥教授介绍了《火针治疗皮肤病经验》等,联盟成员单位的约200名学员参与了培训。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1659899, encodeId=7dd31659899a3, content=<a href='/topic/show?id=ae13245e16c' target=_blank style='color:#2F92EE;'>#京津冀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24571, encryptionId=ae13245e16c, topicName=京津冀)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7e25082405, createdName=achengzhao, createdTime=Wed Oct 10 08:42:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425382, encodeId=24d8142538240, content=<a href='/topic/show?id=e738e2080b4' target=_blank style='color:#2F92EE;'>#皮肤科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72080, encryptionId=e738e2080b4, topicName=皮肤科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65033968588, createdName=zll0626, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463034, encodeId=9faa146303411, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496618, encodeId=5d5514966180d, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525455, encodeId=c9fc15254556e, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88858, encryptionId=08548885835, topicName=融合)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08a911636812, createdName=licz0427, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272484, encodeId=f4cf2e2484f6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Dec 25 21:55:08 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1659899, encodeId=7dd31659899a3, content=<a href='/topic/show?id=ae13245e16c' target=_blank style='color:#2F92EE;'>#京津冀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24571, encryptionId=ae13245e16c, topicName=京津冀)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7e25082405, createdName=achengzhao, createdTime=Wed Oct 10 08:42:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425382, encodeId=24d8142538240, content=<a href='/topic/show?id=e738e2080b4' target=_blank style='color:#2F92EE;'>#皮肤科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72080, encryptionId=e738e2080b4, topicName=皮肤科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65033968588, createdName=zll0626, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463034, encodeId=9faa146303411, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496618, encodeId=5d5514966180d, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525455, encodeId=c9fc15254556e, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88858, encryptionId=08548885835, topicName=融合)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08a911636812, createdName=licz0427, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272484, encodeId=f4cf2e2484f6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Dec 25 21:55:08 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
    2017-12-27 zll0626
  3. [GetPortalCommentsPageByObjectIdResponse(id=1659899, encodeId=7dd31659899a3, content=<a href='/topic/show?id=ae13245e16c' target=_blank style='color:#2F92EE;'>#京津冀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24571, encryptionId=ae13245e16c, topicName=京津冀)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7e25082405, createdName=achengzhao, createdTime=Wed Oct 10 08:42:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425382, encodeId=24d8142538240, content=<a href='/topic/show?id=e738e2080b4' target=_blank style='color:#2F92EE;'>#皮肤科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72080, encryptionId=e738e2080b4, topicName=皮肤科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65033968588, createdName=zll0626, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463034, encodeId=9faa146303411, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496618, encodeId=5d5514966180d, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525455, encodeId=c9fc15254556e, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88858, encryptionId=08548885835, topicName=融合)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08a911636812, createdName=licz0427, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272484, encodeId=f4cf2e2484f6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Dec 25 21:55:08 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1659899, encodeId=7dd31659899a3, content=<a href='/topic/show?id=ae13245e16c' target=_blank style='color:#2F92EE;'>#京津冀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24571, encryptionId=ae13245e16c, topicName=京津冀)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7e25082405, createdName=achengzhao, createdTime=Wed Oct 10 08:42:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425382, encodeId=24d8142538240, content=<a href='/topic/show?id=e738e2080b4' target=_blank style='color:#2F92EE;'>#皮肤科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72080, encryptionId=e738e2080b4, topicName=皮肤科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65033968588, createdName=zll0626, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463034, encodeId=9faa146303411, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496618, encodeId=5d5514966180d, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525455, encodeId=c9fc15254556e, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88858, encryptionId=08548885835, topicName=融合)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08a911636812, createdName=licz0427, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272484, encodeId=f4cf2e2484f6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Dec 25 21:55:08 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
    2017-12-27 zexyw04
  5. [GetPortalCommentsPageByObjectIdResponse(id=1659899, encodeId=7dd31659899a3, content=<a href='/topic/show?id=ae13245e16c' target=_blank style='color:#2F92EE;'>#京津冀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24571, encryptionId=ae13245e16c, topicName=京津冀)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7e25082405, createdName=achengzhao, createdTime=Wed Oct 10 08:42:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425382, encodeId=24d8142538240, content=<a href='/topic/show?id=e738e2080b4' target=_blank style='color:#2F92EE;'>#皮肤科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72080, encryptionId=e738e2080b4, topicName=皮肤科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65033968588, createdName=zll0626, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463034, encodeId=9faa146303411, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496618, encodeId=5d5514966180d, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525455, encodeId=c9fc15254556e, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88858, encryptionId=08548885835, topicName=融合)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08a911636812, createdName=licz0427, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272484, encodeId=f4cf2e2484f6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Dec 25 21:55:08 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
    2017-12-27 licz0427
  6. [GetPortalCommentsPageByObjectIdResponse(id=1659899, encodeId=7dd31659899a3, content=<a href='/topic/show?id=ae13245e16c' target=_blank style='color:#2F92EE;'>#京津冀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24571, encryptionId=ae13245e16c, topicName=京津冀)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7e25082405, createdName=achengzhao, createdTime=Wed Oct 10 08:42:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425382, encodeId=24d8142538240, content=<a href='/topic/show?id=e738e2080b4' target=_blank style='color:#2F92EE;'>#皮肤科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72080, encryptionId=e738e2080b4, topicName=皮肤科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65033968588, createdName=zll0626, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463034, encodeId=9faa146303411, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496618, encodeId=5d5514966180d, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525455, encodeId=c9fc15254556e, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88858, encryptionId=08548885835, topicName=融合)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08a911636812, createdName=licz0427, createdTime=Wed Dec 27 12:42:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272484, encodeId=f4cf2e2484f6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Dec 25 21:55:08 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
    2017-12-25 Y—xianghai

    学习了新知识

    0

相关资讯

陈竺:中西医融合推动癌症研究

       日前,卫生部长陈竺主张除了扩大中美合作以加快抗癌药物的研究之外,还可以将传统中医与现代生物化学相结合用于肿瘤研究。          陈竺部长本人是一名血液学专家,3月6日他在美国纽约与其老师——上海交通大学医学院的王振义院士共同荣获圣捷尔吉癌症研究创新成就奖(Sze

Baidu
map
Baidu
map
Baidu
map